Liquid Biopsy
News and reporting on cell-free DNA testing.
Guardant Health Reveal Assay Gets Additional Medicare Coverage for CRC Surveillance Testing
The test was previously covered for use in colorectal cancer patients in the early postsurgical setting only.
Liquid Biopsy Developer Oxford Cancer Analytics Raises $11M
The company, which is based in England and has operations in Canada, is developing a liquid biopsy test for lung cancer detection.
Myriad Genetics, MD Anderson Partner to Study Clinical Utility of MRD Assay
Under the five-year agreement, the partners will assess the clinical utility of Myriad's Precise MRD test in breast, gastrointestinal, genitourinary, and gynecological cancers.
Most-Read Precision Medicine Stories in 2024
Precision Medicine Online readers were interested in stories about implementation challenges in the space, the first cell therapies for solid tumors, and cardiovascular drugs targeting Lp(a).
Guardant Health, Cota Partner to Provide Clinicogenomic Cancer Data Resource for Biopharma
The companies believe that creating a unified set of clinical and genomic data will help biopharma clients accelerate their development of new targeted therapies.